From Wikipedia, the free encyclopedia
  (Redirected from 2,5-Diketopiperazines)
Jump to: navigation, search
General structure of diketopiperazines
Cyclic dipeptide (2,5-diketopiperazine ) from glycine and L-alanine (left). Cyclodi-L-prolyl (right) formed from two L-proline molecules. The cis-peptide bonds are drawn blue.

A 2,5-Diketopiperazine (2,5-DKP) is a type of cyclic organic compound that results from peptide bonds between two amino acids to form a double lactam. They are the smallest cyclic peptides. In keeping with standard IUPAC organic nomenclature, the "2,5-" designates the atoms on the diketopiperazine ring that are the carbonyls.


The parent compound is 2,5-diketopiperazine, the cyclic compound derived from dehydration of the dipeptide glycylglycine. It was the first peptide to have its complete three-dimensional structure described, in work undertaken Robert Corey in the 1930s.[1]

2,5-Diketopiperazines are commonly biosynthesized from amino acids by a variety of organisms, including mammals, and are considered to be secondary metabolites.[2] Some proteases, such as dipeptidyl peptidases, cleave the terminal ends of proteins to generate dipeptides, which naturally cyclize to form 2,5-diketopiperazines.


Drug design scaffold[edit]

Due to their rigidity, chirality (except for the glycylglycine derivative), and varied side chains, 2,5-diketopiperazines are an attractive scaffolds for drug design.[2] Both natural and synthetic 2,5-diketopiperazines exhibit a variety of biological activities including antitumor,[3] antiviral,[4] antifungal[5] and antibacterial[6] activities.


The diketopiperazine obtains from glycylserine is a reagent for the preparation of C-alkylated derivatives of glycine. This approach is useful for the production of unnatural amino acids with stereochemical control. The diketopiperazine skeleton protects both the N and O termini of the glycine. For this application, the diketopiperazine is O-alkylated with concomitant N-deprotonation to give what is called the Schöllkopf reagent.[7]


  1. ^ Corey, R. B. (1938). "Crystal Structure of Diketopiperazine". Journal of the American Chemical Society 60 (7): 1598–1604. doi:10.1021/ja01274a023. 
  2. ^ a b Martins, M. B.; Carvalho, I. (2007). "Diketopiperazines: Biological Activity and Synthesis". Tetrahedron 63 (40): 9923–9932. doi:10.1016/j.tet.2007.04.105. 
  3. ^ Nicholson, B.; Lloyd, G. K.; Miller, B. R.; Palladino, M. A.; Kiso, Y.; Hayashi, Y.; Neuteboom, S. T. (2006). "NPI-2358 is a Tubulin-depolymerizing Agent: In-vitro Evidence for Activity as a Tumor Vascular-Disrupting Agent". Anti-Cancer Drugs 17 (1): 25–31. doi:10.1097/01.cad.0000182745.01612.8a. PMID 16317287. 
  4. ^ Sinha, S.; Srivastava, R.; de Clercq, E.; Singh, R. K. (2004). "Synthesis and Antiviral Properties of Arabino and Ribonucleosides of 1,3-Dideazaadenine, 4-Nitro-1,3-dideazapurine and Diketopiperazine". Nucleosides, Nucleotides and Nucleic Acids 23 (12): 1815–1824. doi:10.1081/NCN-200040614. PMID 15628741. 
  5. ^ Houston, D. R.; Synstad, B.; Eijsink, V. G.; Stark, M. J.; Eggleston, I. M.; van Aalten, D. M. (2004). "Structure-Based Exploration of Cyclic Dipeptide Chitinase Inhibitors". Journal of Medicinal Chemistry 47 (23): 5713–5720. doi:10.1021/jm049940a. PMID 15509170. 
  6. ^ Kwon, O. S.; Park, S. H.; Yun, B.-S.; Pyun, Y. R.; Kim, C.-J. (2000). "Cyclo(Dehydroala-L-Leu), an α-Glucosidase Inhibitor from Penicillium sp. F70614" (pdf). Journal of Antibiotics 53 (9): 954–958. doi:10.7164/antibiotics.53.954. PMID 11099229. 
  7. ^ Thomas Wirth "New Strategies to α-Alkylated α-Amino Acids" Angewandte Chemie International Edition in English 1997, Volume 36, Issue 3, pages 225–227. doi:10.1002/anie.199702251